274 related articles for article (PubMed ID: 20453750)
1. Levosimendan in cardiac failure after subarachnoid hemorrhage.
Busani S; Rinaldi L; Severino C; Cobelli M; Pasetto A; Girardis M
J Trauma; 2010 May; 68(5):E108-10. PubMed ID: 20453750
[TBL] [Abstract][Full Text] [Related]
2. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
5. Role of levosimendan in the management of subarachnoid hemorrhage.
Varvarousi G; Xanthos T; Sarafidou P; Katsioula E; Georgiadou M; Eforakopoulou M; Pavlou H
Am J Emerg Med; 2016 Feb; 34(2):298-306. PubMed ID: 26669277
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
García González MJ; Domínguez Rodríguez A
Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
[TBL] [Abstract][Full Text] [Related]
7. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
8. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
9. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
10. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study.
Dernellis J; Panaretou M
Chest; 2005 Oct; 128(4):2633-9. PubMed ID: 16236936
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
13. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
Xu CX; Li L; Gong SJ; Yu YH; Yan J
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):423-428. PubMed ID: 29925127
[No Abstract] [Full Text] [Related]
14. Early experience with Levosimendan in children with ventricular dysfunction.
Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
[TBL] [Abstract][Full Text] [Related]
15. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
18. Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
Tarkia M; Stark C; Haavisto M; Kentala R; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teräs M; Pietilä M; Nyman L; Duvall E; Saukko P; Levijoki J; Roivainen A; Saraste A; Knuuti J
Heart; 2016 Mar; 102(6):465-71. PubMed ID: 26762238
[TBL] [Abstract][Full Text] [Related]
19. Severe stunned myocardium after lightning strike.
Rivera J; Romero KA; González-Chon O; Uruchurtu E; Márquez MF; Guevara M
Crit Care Med; 2007 Jan; 35(1):280-5. PubMed ID: 17133184
[TBL] [Abstract][Full Text] [Related]
20. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
